Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2009
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625897 5-[6-Chloro-2-fluoro-3-((R)-5-methyl-6-oxo-1,4,5,6-tetrahydro-[1,2,4]triazin-3-ylmethyl)-phenoxy]-isophthalonitrile; contacting a phenylacetic acid compound with an amino acid ester in presence of a coupling reagent to produce an intermediate, then with Lawesson's reagent, finally with hydrazine; AIDS
12/01/2009US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma
12/01/2009US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections
12/01/2009US7625879 Phosphohalohydrins, process for the production thereof and use thereof
12/01/2009US7625875 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
12/01/2009US7625751 WNV core protein/capsid interacting protein and uses of the same
12/01/2009US7625713 Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide
12/01/2009US7625579 A substrate having a vapor deposited furanone compounds, covalent bonding through etherification or amination; protective coatings on medical equipment, seeds, fibrics, wool, hair, silk, cotton, chitin, collagen, animal
12/01/2009US7625573 Immunology active materials; anticancer agents, infections, autoimmune diseases, parasiticides; lipid bilayer with antitumor agent
12/01/2009US7625566 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides
12/01/2009CA2572461C Physiological compatible film
12/01/2009CA2555213C Nucleoside phosphonate derivatives useful in the treatment of hiv infections
12/01/2009CA2461100C 4-imidazolin-2-one compounds
12/01/2009CA2442311C Amorphous cefditoren pivoxil composition and process for producing the same
12/01/2009CA2432121C Nitric oxide synthase inhibitor phosphate salt
12/01/2009CA2407210C Liposome drug delivery
12/01/2009CA2298956C Genetically engineered cell culture adapted infectious bursal diseases virus (ibdv) mutants
11/2009
11/26/2009WO2009143483A2 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION
11/26/2009WO2009143345A2 Nucleic acid silencing agent-protein conjugates and use thereof for treating hcv-related disorders
11/26/2009WO2009143133A2 Compositions and methods to protect cells by blocking entry of pathogen proteins
11/26/2009WO2009143024A2 Compounds and methods for kinase modulation, and indications therefor
11/26/2009WO2009143018A2 Compounds and methods for kinase modulation, and indications therefor
11/26/2009WO2009142761A1 Caspofungin bo free of caspofungin co
11/26/2009WO2009142672A2 Antimicrobial and odor adsorbing textile
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009142086A1 Vaccine composition for mycoplasma infection
11/26/2009WO2009141524A1 Method for obtaining an extract of cranberry marc that can be used in particular in the prevention and treatment of conditions such as caries, gingivitis or sore throats
11/26/2009WO2009141455A1 Immunogenic polypeptides that mimic the surface polysaccharide o-antigen from serotype 2a shigella flexneri, method for obtaining the same, and their use in vaccine and diagnostic compositions
11/26/2009WO2009141399A1 Tricyclic nitrogen containing compounds and their use as antibacterials
11/26/2009WO2009141398A1 Tricyclic nitrogen containing compounds and their use as antibacterials
11/26/2009WO2009140984A1 Anhydrous and hydrate forms of crystalline 2- ( (2s, 3r, 4e, 6e, 1oe, 12s) -13- (4-fluorophenoxy) -2,3, 12- (trihydroxytrideca-4, 6, 10-trien-8-ynyl) oxy) acetic acid
11/26/2009WO2009140853A1 Combination therapy for the treatment of influenza
11/26/2009WO2009116044A3 Guanine nucleotide derivatives for treating bacterial infections
11/26/2009WO2009071959A3 Composition containing itraconazole
11/26/2009WO2009058387A3 Oligomer-nitroimidazole anti-infective conjugates
11/26/2009WO2009043458A3 Use of oxytocin to treat many diseases
11/26/2009WO2009043457A3 Use of human hemokinin-1 and optionally oxytocin to treat diseases involving excessive angiogenesis
11/26/2009WO2009040024A3 Use of bim-23127 and optionally urodilatin as therapeutic agents eg for the treatment of m. tuberculosis infections
11/26/2009WO2009039981A3 Use of (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009039980A3 Use of bfgf 1-24 and optionally (arg 8) vasopressin to treat eg s. pneumoniae infection
11/26/2009WO2009033820A3 Use of saralasin and carbetocin in combination to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033783A3 Use of carbetocin to treat of eg aids or idiopathic pulmonary fibrosis
11/26/2009WO2009033782A3 Use of a teprotide and optionally carbetocin to treat eg aids or idiopathic pulmonay fibrosis
11/26/2009US20090292113 Recombinant soluble Fc receptors
11/26/2009US20090292005 L- alpha -dioleoyl phosphatidyl{14-N-(1-deoxylactito-1-yl)amino-3,6,9,12-tetraoxa}tetra decanol; 2-O-{2-N-(1-deoxylactito-1-yl)aminoethyl} carbamoyl-1,3-O-dioleoyl glycerol; galactose, a suitable spacer and a certain lipid, a drug carrier; efficiently transferred into the liver
11/26/2009US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009US20090291996 Caspofungin free of caspofungin Co
11/26/2009US20090291990 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
11/26/2009US20090291964 Potentiators of Antibacterial Activity
11/26/2009US20090291952 Modulators of pharmacokinetic properties of therapeutics
11/26/2009US20090291943 Process for preparing diaminophenothiazinium compounds
11/26/2009US20090291925 Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
11/26/2009US20090291908 Use of thiophoshonoformic acid and nrtis to treat viral infections
11/26/2009US20090291905 Fungal phytotoxin fusicoccin for the treatment and diagnosis of coagulation-correlated pathologies
11/26/2009US20090291902 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/26/2009US20090291898 Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity
11/26/2009US20090291884 Proteins for use in diagnosing and treating infection and disease
11/26/2009US20090291881 Coatings for drug delivery devices
11/26/2009US20090291118 Universal barrier to prevent infections from human immunodeficiency virus
11/26/2009US20090291117 Female barrier to prevent infections from human immunodeficiency virus
11/26/2009US20090291070 Biologically Active Silver-Coated Proteins
11/26/2009US20090291069 Novel strain of the genus lactobacillus and topical pharmaceutical formulations containing it
11/26/2009US20090291060 Treatment of HIV
11/26/2009CA2725726A1 Tricyclic nitrogen containing compounds and their use as antibacterials
11/26/2009CA2725329A1 Nanoemulsion vaccines
11/26/2009CA2724897A1 Salts and polymorphs of a tetracycline compound
11/26/2009CA2724569A1 Compositions and methods to protect cells by blocking entry of pathogen proteins
11/26/2009CA2724357A1 Novel thiophenediamine derivative having urea structure
11/26/2009CA2720729A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/25/2009EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use
11/25/2009EP2123668A1 Immunogenic polypeptides that mimic the surface polysaccharide O-antigen from serotype 2A shigella flexneri, method for obtaining the same, and their use in vaccine and diagnostic compositions
11/25/2009EP2123662A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound
11/25/2009EP2123300A1 Medicinal agent for treating bird flu
11/25/2009EP2123297A1 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient
11/25/2009EP2123282A2 Immunemodulating oligosaccharides
11/25/2009EP2123276A1 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
11/25/2009EP2123271A1 Drug for treatment of influenza
11/25/2009EP2123173A1 Method of feeding mother pig
11/25/2009EP2123172A1 Method of preventing diseases in piglings in the weaning stage
11/25/2009EP2121719A2 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
11/25/2009EP2121716A1 Compositions of stable tiacumicins
11/25/2009EP2121714A1 Aminoglycoside antibiotics targeting bacterial 16s ribosomal rna
11/25/2009EP2121697A1 Compounds for the treatment of hepatitis c
11/25/2009EP2121676A1 Preperation and utility of ccr5 inhibitors
11/25/2009EP2121593A1 Transdermal delivery systems of beta-lactam antibiotics
11/25/2009EP2121572A2 Preparation and utility of substituted allylamines
11/25/2009EP2120974A1 Self-assembling amphiphilic polymers as antiviral agents
11/25/2009EP2120960A2 NOVEL ß-LACTAM ANTIBIOTICS, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF
11/25/2009EP2120952A2 Antiviral compounds and methods of using thereof
11/25/2009EP2120908A1 Solvating system and sealant for medical use
11/25/2009EP2120903A1 Antibacterial formulations
11/25/2009EP2120569A2 Spirochromanon derivatives
11/25/2009EP2120567A1 Prodrugs of substituted 1,3-dioxanes and their uses
11/25/2009EP1930407B1 Novel bacterium belonging to the genus bifidobacterium and utilization of the same
11/25/2009EP1899331B1 Homomorpholine oxazolidinones as antibacterial agents
11/25/2009EP1658373B1 Co-expression vector for the membrane domains of viral envelope proteins and uses thereof
1 ... 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 ... 1798